ReviewInflammopharmacology2025
A comprehensive review on anti-inflammatory plants: a mechanistic insight through preclinical and clinical studies.
Review in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- From Activity Screening to Quality Control: UHPLC-MS/MS Analysis of Anti-Inflammatory Cyclodipeptides inMolecules (Basel, Switzerland) · 2026Article
- Plant-Based Nano-Delivery Systems in the Treatment of Inflammatory Disorders.Pharmaceutics · 2026Review
- Green biosynthesized silver nanoparticles using aqueous extract of Salix alba: antimicrobial and cytogenetic effects on mitosis.F1000Research · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory diseases are a leading cause of morbidity and mortality worldwide, necessitating the exploration of novel therapeutic agents. Natural products, particularly plant-derived compounds, have emerged as promising candidates for managing inflammation due to their diverse bioactive constituents and significant safety. The present review provides a comprehensive analysis of the anti-inflammatory potential of medicinal plants, their mechanisms of action, and their therapeutic relevance in preclinical and clinical studies. A total of 94 medicinal plants and isolated compounds with reported anti-inflammatory activities have been discussed, with their mode of action including different signaling pathways, viz., inhibition of COX, LOX, cytokine modulation, and oxidative stress reduction. Despite substantial preclinical validation, the translation of these findings into clinical applications remains limited. Further research focusing on bioactive compound isolation, molecular pharmacology, and clinical trials is essential to establish plant-based therapeutics as viable alternatives to conventional anti-inflammatory drugs.
Indexed as
Identifiers
40465037What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.